ABEO
Abeona Therapeutics Inc
5.00$
+0.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
Abeona Therapeutics Inc (ABEO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -76 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.7 | -3.6 | -3.2 | -3.2 | -4.3 | -5.3 | -8.6 | -6.4 | -9.1 | -7.3 | -2.0 | 4.8 | -6.6 | -2.2 | -6.9 | -7.6 | -4.0 | 0.0 | -1.6 | -10 | -13 | -23 | -39 | -63 | -35 | -66 | -43 | -37 | -56 | -76 | |
| 0.1 | 0.2 | 0.2 | 0.3 | 0.5 | 0.6 | 0.7 | 0.9 | 1.1 | 1.6 | 7.1 | 2.6 | 0.3 | 0.3 | 0.2 | 0.2 | 0.4 | 0.0 | 0.0 | 0.6 | 0.8 | 0.7 | 2.4 | 8.7 | 5.6 | 4.5 | 4.6 | 3.2 | 2.9 | 3.6 | |
| – | – | – | – | – | – | – | – | – | 42 | – | 77 | – | 0.8 | 1.0 | 1.1 | 0.4 | 0.4 | 1.3 | 4.4 | 4.8 | 5.9 | 8.9 | 8.2 | 8.2 | 8.9 | 3.1 | 4.8 | 6.6 | 11 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -7.7 | 25 | 4.8 | 4.8 | 4.5 | 7.6 | 7.3 | 42 | 33 | – | – | – | – | |
| 0.0 | -0.1 | 1.2 | -0.2 | 0.3 | 0.1 | -0.7 | -0.4 | 0.0 | 3.0 | 3.0 | 1.5 | 0.7 | 3.7 | -2.2 | -0.7 | -0.2 | 3.1 | 0.4 | -6.1 | -0.2 | -2.1 | 7.0 | -3.6 | 1.6 | -18 | -5.9 | -1.8 | -4.4 | -5.4 | |
| 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.4 | 0.4 | 0.5 | 0.2 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.3 | 0.5 | 0.9 | 19 | 6.5 | 1.3 | 4.2 | 0.1 | 0.3 | 2.4 | 8.0 | |
| 0.0 | -0.2 | -0.1 | -0.1 | -17 | 3.7 | 2.7 | 6.0 | 1.2 | 9.7 | -2.5 | -3.6 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.4 | 3.4 | -0.5 | -0.9 | -85 | 60 | -84 | 66 | -24 | 0.2 | -39 | 105 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 19 | 82 | 168 | 271 | 319 | 2.9 | 11,579 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| – | – | – | – | -0.8 | – | – | – | – | – | – | – | -2,425 | – | – | 2,750 | -4,335 | 0.0 | 12 | 12 | 43 | 92 | 5.5 | 18 | 0.2 | 0.0 | -26 | -0.2 | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.4 | -0.4 | – | 1.8 | 1.8 | 1.8 | 1.8 | 0.0 | – | 0.0 | 20 | 0.0 | |
| 7.1 | -0.2 | 4.4 | 2.7 | 29 | 0.6 | -0.1 | -0.4 | 9.0 | -3.8 | 5.3 | 7.4 | 2.4 | 0.2 | 13 | 3.1 | 1.9 | 0.0 | 13 | 36 | 43 | 92 | 5.5 | 114 | 1.9 | 25 | 43 | 37 | 104 | 26 | |
| 4.4 | -4.0 | 1.1 | -0.6 | 7.5 | -1.0 | -6.0 | -0.7 | 1.0 | -1.4 | 0.8 | 8.7 | -4.3 | -2.1 | 6.4 | -4.6 | -2.1 | 0.0 | 11 | 29 | 29 | 69 | -119 | 111 | -117 | 25 | -24 | 0.3 | 8.9 | 55 | |
| -2.7 | -3.6 | -3.3 | -3.3 | -4.4 | -5.7 | -9.0 | -6.8 | -9.3 | -7.3 | -2.0 | 4.8 | -6.7 | -2.3 | -6.9 | -7.6 | -4.0 | 0.0 | -1.6 | -11 | -14 | -24 | -59 | -69 | -36 | -70 | -44 | -37 | -58 | -84 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.